Literature DB >> 18226555

Familial osteochondritis dissecans associated with early osteoarthritis and disproportionate short stature.

E-L Stattin1, Y Tegner, M Domellöf, N Dahl.   

Abstract

OBJECTIVE: Familial osteochondritis dissecans (OCD) is a rare disorder characterised by disturbed chondro-skeletal development, disproportionate growth and deformation of the skeleton.
DESIGN: We identified a five-generation family with 15 living affected members from Northern Sweden. The disorder was diagnosed with a case definition of OCD in at least one joint.
RESULTS: Main clinical findings consisted of OCD in knees and/or hips and/or elbows, disproportionate short stature and early osteoarthritis (OA). There were no radiological indications of epiphyseal dysplasia. Anthropometric measurements of affected individuals showed short stature, a high ratio between sitting height and total height, a relatively normal arm span and head circumference. In 12 of 15 cases, onset was during late childhood or adolescence and OA had developed in seven of those patients.
CONCLUSIONS: Our observation suggests that OA is a frequent complication in familial OCD even though the lesions appear before closure of physis.

Entities:  

Mesh:

Year:  2008        PMID: 18226555     DOI: 10.1016/j.joca.2007.11.009

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  22 in total

1.  Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations.

Authors:  Ola Nilsson; Michael H Guo; Nancy Dunbar; Jadranka Popovic; Daniel Flynn; Christina Jacobsen; Julian C Lui; Joel N Hirschhorn; Jeffrey Baron; Andrew Dauber
Journal:  J Clin Endocrinol Metab       Date:  2014-04-24       Impact factor: 5.958

Review 2.  Cartilage diseases.

Authors:  Yamini Krishnan; Alan J Grodzinsky
Journal:  Matrix Biol       Date:  2018-05-24       Impact factor: 11.583

3.  Osteochondritis Dissecans Lesions in Family Members: Does a Positive Family History Impact Phenotypic Potency?

Authors:  Alex L Gornitzky; R Justin Mistovich; Brittany Atuahuene; Eileen P Storey; Theodore J Ganley
Journal:  Clin Orthop Relat Res       Date:  2017-06       Impact factor: 4.176

Review 4.  Osteochondritis dissecans knee histology studies have variable findings and theories of etiology.

Authors:  Kevin G Shea; John C Jacobs; James L Carey; Allen F Anderson; Julia T Oxford
Journal:  Clin Orthop Relat Res       Date:  2013-04       Impact factor: 4.176

5.  Idiopathic short stature due to novel heterozygous mutation of the aggrecan gene.

Authors:  Jose Bernardo Quintos; Michael H Guo; Andrew Dauber
Journal:  J Pediatr Endocrinol Metab       Date:  2015-07       Impact factor: 1.634

6.  A balanced reciprocal translocation t(10;15)(q22.3;q26.1) interrupting ACAN gene in a family with proportionate short stature.

Authors:  M Crippa; S Giangiobbe; R Villa; I Bestetti; T De Filippis; L Fatti; J Taurino; L Larizza; L Persani; F Bellini; P Finelli; M T Bonati
Journal:  J Endocrinol Invest       Date:  2018-01-04       Impact factor: 4.256

7.  Identification of a novel heterozygous mutation of the Aggrecan gene in a family with idiopathic short stature and multiple intervertebral disc herniation.

Authors:  Sumito Dateki; Akiko Nakatomi; Satoshi Watanabe; Hitomi Shimizu; Yukiko Inoue; Hideo Baba; Koh-Ichiro Yoshiura; Hiroyuki Moriuchi
Journal:  J Hum Genet       Date:  2017-03-23       Impact factor: 3.172

8.  Is vitamin D insufficiency or deficiency related to the development of osteochondritis dissecans?

Authors:  Juergen Bruns; Mathias Werner; Matthias Soyka
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-11-05       Impact factor: 4.342

Review 9.  Emerging genetic basis of osteochondritis dissecans.

Authors:  J Tyler Bates; John C Jacobs; Kevin G Shea; Julia Thom Oxford
Journal:  Clin Sports Med       Date:  2014-01-10       Impact factor: 2.182

10.  Fluoroquinolone use in a child associated with development of osteochondritis dissecans.

Authors:  John C Jacobs; Kevin G Shea; Julia Thom Oxford; James L Carey
Journal:  BMJ Case Rep       Date:  2014-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.